ConductScience.org, home

Trial · NCT07332273

Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.

NCT07332273, Phase 3, Recruiting, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity. Trials, record NCT07332273. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07332273

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.
NCT number
NCT07332273
Status
Recruiting
Phases
Phase 3
Enrollment
286 participants, estimated
Lead sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Conditions
Obesity
Interventions
Levothyroxine, Placebo
First posted
2026-01-12
Last updated
2026-01-12

Source ClinicalTrials.gov

Registered outcomes23

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in body weight (kg) from baseline to Month 3Baseline to Month 3 (12 weeks ±2)
PrimaryChange in fat mass (kg) by bioimpedance from baseline to Month 3Baseline to Month 3 (12 weeks ±2)
SecondaryWeight-regain (kg) from Month 3 to Month 9Month 3 to Month 9 (36 weeks ±2)
SecondaryChange in BMI (kg/m²) from baseline to Month 9Baseline to Month 9
SecondaryChange in waist circumference (cm) from baseline to Month 9Baseline to Month 9
SecondaryChange in fasting LDL-cholesterol (mg/dL) from baseline to Month 9Baseline to Month 9
SecondaryChange in glycaemic control (HbA1c, %) from baseline to Month 9Baseline to Month 9
SecondaryChange in insulin resistance (HOMA-IR) from baseline to Month 9Baseline to Month 9
SecondaryChange in resting energy expenditure (kcal/day) by indirect calorimetry from baseline to Month 9Baseline to Month 9
SecondaryChange in physical activity level measured by accelerometryBaseline to Month 9Physical activity will be quantified by accelerometry using the ActiGraph WGT3X-BT device, worn for 7 consecutive days before and after the intervention periods, as specified in the protocol.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07332273

GET https://conductscience.org/api/trials/v1/NCT07332273/registered?page=2